--- title: "ACCURAY INC (ARAY) stock listing, news and investor profile" url: "https://aibio.space/companies/accuray/" publisher: "aibio.space (Biotech Investor Relations News)" summary: "ACCURAY INC (NASDAQ: ARAY), United States. Listing facts, related biotech companies and news on aibio.space." --- ARAY ACCURAY INC NASDAQ · United States # ACCURAY INC (ARAY) news Debt Financing · 2026-07-29 ## [Accuray gets lender waiver of defaults under financing agreement](https://aibio.space/news/accuray-gets-lender-waiver-defaults-under-financing-agreement/) Accuray's lenders waived two defaults under its financing agreement, and the same amendment exchanges converted debt for preferred shares and penny warrants, subject to shareholder approval. ## Latest ACCURAY INC news We have not published a story on ACCURAY INC yet. When there is news, it will appear here. ## ACCURAY INC at a glance - **Ticker**: ARAY - **Listing**: NASDAQ - **Country**: United States - **Cash, Jun 30, 2026**: $40.6 million ### Related companies - [Green Planet Bio Engineering Co.](https://aibio.space/companies/green-planet-bio-engineering/) OTC: GPLB - [Lumexa Imaging Holdings](https://aibio.space/companies/lumexa-imaging/) NASDAQ: LMRI - [TELEFLEX INC](https://aibio.space/companies/teleflex/) NYSE: TFX - [BIOFORCE NANOSCIENCES HOLDINGS, INC.](https://aibio.space/companies/bioforce-nanosciences/) OTC: BFNH - [Modular Medical](https://aibio.space/companies/modular-medical/) NASDAQ: MODD - [Bespoke Extracts](https://aibio.space/companies/bespoke-extracts/) OTC: BSPK - [QUEST DIAGNOSTICS INC](https://aibio.space/companies/quest-diagnostics/) NYSE: DGX - [DEXCOM INC](https://aibio.space/companies/dexcom/) NASDAQ: DXCM ### Also on NASDAQ - [Lantern Pharma](https://aibio.space/companies/lantern-pharma/) LTRN - [Heron Therapeutics](https://aibio.space/companies/heron-therapeutics/) HRTX - [Silence Therapeutics](https://aibio.space/companies/silence-therapeutics/) SLN - [VERACYTE, INC.](https://aibio.space/companies/veracyte/) VCYT - [CAMP4 Therapeutics](https://aibio.space/companies/camp4-therapeutics/) CAMP - [Belite Bio](https://aibio.space/companies/belite-bio/) BLTE ## What ACCURAY INC does Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions. Its portfolio includes the CyberKnife robotic platform and a helical portfolio of Accuray Stellar, Radixact, Accuray Helix and Tomo C systems, where available. Its systems are designed to support SRS, SBRT, IMRT, IGRT and adaptive radiation therapy, with software for motion management, treatment planning, anatomical change detection and retreatment planning. ClearRT helical kVCT imaging is available on selected systems and configurations. The CyberKnife platform is also used by neurosurgeons for radiosurgery of brain and spine tumors, and for selected neurologic and endocrine disorders where clinically appropriate. The company also provides customer support, installation, training and other professional services. Accuray was incorporated in California in 1990, reincorporated in Delaware in 2007, and has its principal United States office in Madison, Wisconsin. | Product or program | What it is | Stage | |---|---|---| | CyberKnife | Robotic radiation therapy platform | | | Accuray Stellar | Helical radiation therapy system with motion management | | | Radixact | Helical radiation therapy system | | | Accuray Helix | Helical radiation therapy system | | Summarised from the company's [10-K filed Aug 27, 2026](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/aray20260630_10k.htm). ## ACCURAY INC annual financials | Line | FY ended Jun 30, 2026 | FY ended Jun 30, 2025 | |---|---|---| | Revenue | [$401.9 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | [$458.5 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | | Research and development | [$37.8 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | [$47.9 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | | Net income (loss) | [-$49.2 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | [-$1.6 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | | Cash from operations | [-$7.0 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | [$2.9 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | | Cash and equivalents | [$40.6 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | [$57.4 million](https://www.sec.gov/Archives/edgar/data/1138723/000143774926029098/) | Latest balance sheet, Jun 30, 2026 (10-K): cash and equivalents $40.6 million. Figures as reported to the SEC in XBRL; each one links to its filing. Not adjusted, not investment advice. ## Questions about ACCURAY INC What is the ticker symbol of ACCURAY INC? ACCURAY INC trades under the ticker ARAY on NASDAQ. Where is ACCURAY INC listed? ACCURAY INC is listed on NASDAQ. Which country or territory is ACCURAY INC listed under? Our directory records ACCURAY INC under United States. Does aibio.space cover ACCURAY INC? aibio.space lists ACCURAY INC among 2,820 public biotech companies and publishes its news here as stories appear. What does ACCURAY INC develop? Accuray Incorporated is a radiation therapy company that develops, manufactures, sells and supports treatment delivery, planning, imaging and data management solutions. Its portfolio includes the CyberKnife robotic platform and a helical portfolio of Accuray Stellar, Radixact, Accuray Helix and Tomo C systems, where available. What is CyberKnife from ACCURAY INC? CyberKnife: Robotic radiation therapy platform Stage: stage not stated. What is Accuray Stellar from ACCURAY INC? Accuray Stellar: Helical radiation therapy system with motion management Stage: stage not stated. What was ACCURAY INC's revenue last year? $401.9 million for the fiscal year ended Jun 30, 2026, as reported to the SEC. Is ACCURAY INC profitable? ACCURAY INC reported a net loss of $49.2 million for the fiscal year ended Jun 30, 2026, and used $7.0 million of cash in operations, per its annual report to the SEC. How much does ACCURAY INC spend on research and development? $37.8 million in the fiscal year ended Jun 30, 2026, per its annual report. How much cash does ACCURAY INC have? $40.6 million in cash at Jun 30, 2026, per its 10-K. What is the latest ACCURAY INC (ARAY) stock news? Our latest story on ACCURAY INC, dated Jul 29, 2026: "Accuray gets lender waiver of defaults under financing agreement". Accuray's lenders waived two defaults under its financing agreement, and the same amendment exchanges converted debt for preferred shares and penny warrants, subject to shareholder approval. [Source](https://aibio.space/news/accuray-gets-lender-waiver-defaults-under-financing-agreement/). Does ACCURAY INC have debt, a term loan or convertible notes? Our latest debt story, dated Jul 29, 2026: "Accuray gets lender waiver of defaults under financing agreement". Accuray's lenders waived two defaults under its financing agreement, and the same amendment exchanges converted debt for preferred shares and penny warrants, subject to shareholder approval. [Source](https://aibio.space/news/accuray-gets-lender-waiver-defaults-under-financing-agreement/). How can I follow ACCURAY INC (ARAY) news? Press Follow on this page to add ACCURAY INC to your Following list, or subscribe to the aibio.space newsletter. We have published 1 story naming ACCURAY INC so far, in Debt Financing. ## Investor discussion: ACCURAY INC Members talk about ACCURAY INC (ARAY). Reader posts, not aibio.space reporting, and not investment advice. Rules 1. **Securities violations are strictly forbidden.** No market manipulation, no pump-and-dump, no false or misleading statements, and no inside information. 2. **Say whether you hold the stock.** Every post states long, short or no position. 3. **No paid or sponsored posts.** Do not post for anyone who pays or rewards you. 4. **No buy or sell calls and no price targets.** 5. **No accusations of crime or fraud against named people** unless you link a court filing or a regulator's release that makes them. 6. **No personal details and no spam.** No links at all for your first 7 days as a member. Posts that break the rules may be deleted without notice, and the account restricted or closed. See the [terms](https://aibio.space/terms/#discussion) and the [privacy policy](https://aibio.space/privacy/#discussion). ## Capital-markets timeline Financings, listing notices, splits, legal actions and other investor events at ACCURAY INC, newest first. Each line links the filing it comes from. 1. 2026-10-06 Listings Reported a shareholder vote on a reverse stock split or more authorized shares. SEC Form 8-K (Items 5.02,5.07,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1138723/000143774926032174/aray20261005_8k.htm) 2. 2026-08-24 Listings Asked shareholders to approve a reverse stock split. SEC Form DEF 14A. [Source](https://www.sec.gov/Archives/edgar/data/1138723/000114036126034187/ny20079885x2_def14a.htm) 3. 2026-08-12 Listings Asked shareholders to approve a reverse stock split. SEC Form PRE 14A. [Source](https://www.sec.gov/Archives/edgar/data/1138723/000114036126032542/ny20079885x1_pre14a.htm) 4. 2026-08-06 Listings Reported a notice from its stock exchange about continued listing requirements. SEC Form 8-K (Items 3.01). [Source](https://www.sec.gov/Archives/edgar/data/1138723/000143774926026250/aray20260805_8k.htm) 5. 2026-07-29 Financings Reported a financing. SEC Form 8-K (Items 1.01,3.02,5.02,8.01,9.01). [Source](https://www.sec.gov/Archives/edgar/data/1138723/000143774926024904/ex_995021.htm) 6. 2026-06-04 Distress Reported the end of a material agreement. SEC Form 8-K (Items 1.02,7.01). [Source](https://www.sec.gov/Archives/edgar/data/1138723/000143774926019558/aray20260603_8k.htm) ## Stock chart Price chart and quote supplied by TradingView, delayed as the exchange requires. It loads only if you choose to show it. Information only, not investment advice. [Open NASDAQ:ARAY on TradingView](https://www.tradingview.com/symbols/NASDAQ-ARAY/). ## Listing details ACCURAY INC is a public biotech or pharmaceutical company listed on NASDAQ under the ticker ARAY, recorded under United States. aibio.space tracks 2,820 public biotech companies worldwide and publishes investor news on them. - **Company**: ACCURAY INC - **Ticker**: ARAY - **Listing**: NASDAQ - **Country or territory**: United States Listing facts come from our company directory, researched on October 22, 2026. A listing record does not certify that a security currently trades. [Tell us about a change](https://aibio.space/reputation/#update). Work at this company? [Claim this page](https://aibio.space/claim/). Published and maintained by aibio.space. Not investment advice. [How we work](https://aibio.space/disclosures/). Who manages this page **This page is managed by aibio.space.** The company does not run, edit or pay for this page. News, desk views and Investor Ranks are written and managed independently by aibio.space under our editorial and analytical judgment. Opinion only, not investment advice. [How we work](https://aibio.space/disclosures/#paid) · [Terms](https://aibio.space/terms/#news) · [Request a correction](https://aibio.space/reputation/#update) --- Source page: https://aibio.space/companies/accuray/. Facts in aibio.space stories are checked against company filings and releases; opinion is labelled. Cite as: aibio.space, "ACCURAY INC (ARAY) stock listing, news and investor profile", 2026-10-31, https://aibio.space/companies/accuray/